The Strengths and Difficulties Questionnaire (SDQ; [@bibr9-1073191118804082]) aims at measuring psychosocial functioning among children and adolescents aged 4 to 17 years. This widely used questionnaire is valued for three reasons. First, with only 25 items, the SDQ is relatively short. Second, the SDQ not only covers deficits (hyperactivity/inattention, conduct problems, emotional problems, peer problems) but also strengths (prosocial behavior). Third, the availability of multiple informant versions allows an individual's psychosocial functioning to be assessed from multiple perspectives. For adolescents aged 11 to 16 years, an adolescent version (also known as the self-report version) and a parent version can be completed. A teacher version is also available, but as adolescents no longer spend the vast part of their school day with one or two teachers, teachers are increasingly often passed over as informants during adolescence.

The SDQ is typically used for screening and clinical assessment purposes. The usefulness of an instrument for these purposes can be judged against the standards of evidence-based assessment (e.g., [@bibr13-1073191118804082]; [@bibr34-1073191118804082]). According to these standards, an instrument is useful if it can be applied to predict an important criterion, prescribe a certain type of treatment or monitor an individual's progress ([@bibr34-1073191118804082]). With these applications in mind, sound evidence for an instrument's psychometric properties is regarded as an essential prerequisite ([@bibr33-1073191118804082]). For the use of the SDQ among adolescents, multiple studies have provided insight into the psychometric properties of the SDQ parent and adolescent versions (e.g., [@bibr10-1073191118804082]; [@bibr30-1073191118804082]; [@bibr31-1073191118804082]). Two matters warrant further investigation. First, although the presumed five-factor structure ([@bibr9-1073191118804082], [@bibr10-1073191118804082]) of both the SDQ adolescent and the SDQ parent version has repeatedly been investigated in community settings, it has hardly been in clinical settings. Second, although the measurement invariance of both SDQ versions across demographic variables such as age, gender, and ethnicity has been investigated among adolescents, measurement invariance across adolescent community and clinical settings has not been addressed previously. The aim of the present study was to address these issues.

For the SDQ *adolescent* version, the presumed five-factor structure has not been investigated in clinical populations. In community populations, several studies addressed this matter. Some studies confirmed the five-factor structure ([@bibr10-1073191118804082]; [@bibr15-1073191118804082]; [@bibr22-1073191118804082]; [@bibr24-1073191118804082]; [@bibr31-1073191118804082]), while others could only partially confirm or could not ([@bibr3-1073191118804082]; [@bibr7-1073191118804082]; [@bibr14-1073191118804082]; [@bibr20-1073191118804082]; [@bibr23-1073191118804082]; [@bibr30-1073191118804082]). The mixed nature of the results can possibly be explained by differences in sample characteristics. For instance, all studies were performed among youths between the ages of 10 and 19 years, but some studies covered that whole age range, while others only covered 2 or 3 years of age (e.g., 14-15 or 16-18 years). The samples further differed in country of origin; most of the studies mentioned were performed in Northeast Europe, whereas others were performed in Greece, Russia, Spain, and the United States. Cultural differences may underlie differences in the way the SDQ measures psychosocial functioning.

For the SDQ *parent* version, the few previous studies yielded support for the presumed five-factor structure of this SDQ version in community populations ([@bibr11-1073191118804082]; [@bibr31-1073191118804082], respectively) and a clinical population ([@bibr1-1073191118804082]). However, the findings in the clinical population are of limited value for adolescents, since the clinical sample consisted of both adolescents and children without distinguishing between the two.

Considering the somewhat mixed results on the tenability of the five-factor structure regarding the SDQ adolescent self-report version, an alternative six-factor solution has been investigated ([@bibr31-1073191118804082]). This six-factor solution consists of the five factors as intended by [@bibr9-1073191118804082], and an additional *positive construal method* factor. The latter is composed of the positively worded items, five in total, from the four difficulties scales. Such positively worded items tend to cluster together based on item stem similarity, regardless of the trait that they are supposed to measure (e.g., [@bibr21-1073191118804082]; [@bibr26-1073191118804082]). The positive method factor thus expresses the method effect bias resulting from combining positively and negatively worded items in the SDQ problem scales.

Besides further investigation into how each SDQ version measures psychosocial functioning among adolescents in clinical and community settings, research is needed on whether the SDQ measures strengths and difficulties in the same way in both settings. The latter is highly relevant as it provides insight into the comparability of SDQ scores obtained in a clinical setting and SDQ scores obtained in a nonclinical setting. To sensibly compare SDQ scores across settings, measurement invariance is a prerequisite. A violation of measurement invariance occurs, for instance, when adolescents who complete the SDQ for the clinical assessment purposes at an institution for youth mental health care, interpret questions differently from adolescents who complete the questionnaire as part of a general health checkup at school. This would be problematic because a very same SDQ score gathered in the two settings can bear a different meaning in terms of severity of the adolescents' problems. We are aware of only one study examining measurement invariance across community and clinical settings: [@bibr27-1073191118804082] found evidence for measurement invariance across these populations for the five-factor SDQ parent version among 2- to 14-year-olds. To the best of our knowledge, measurement invariance across these settings among adolescents has not been investigated.

The aim of the current study is to assess the presumed five-factor structure of the SDQ adolescent and the parent versions, and to examine their measurement invariance across community and clinical populations of Dutch adolescents aged 12 to 17 years. In case the presumed five-factor structure does not fit adequately, we will investigate the six-factor structure, including the *positive construal method factor*. Additionally, this study assesses the way the SDQ scores are currently calculated in practice: summing item scores per SDQ scale, using equal weighting of items per scale. For the *parent* version, we hypothesize to find confirmation for the presumed five-factor structure in the community and in the clinical populations, corroborating previous findings ([@bibr1-1073191118804082]; [@bibr11-1073191118804082]; [@bibr31-1073191118804082]). Furthermore, we hypothesize to find measurement invariance of the five-factor SDQ parent version across the two populations, consistent with findings by [@bibr27-1073191118804082], thereby assuming that the parent's manner of judgment regarding an adolescent's psychosocial functioning does not substantially differ from their manner of judgment of younger children's psychosocial functioning. As the five-factor structure closely resembles how SDQ scale scores are calculated in practice (i.e., summing item scores per scale), we hypothesize to find reassurance for this sum score method.

For the SDQ *adolescent* version, we cautiously expect to find confirmation for the presumed five-factor structure as findings from previous research regarding factor structure in community populations are mixed. With regard to the factor structure of the *adolescent* SDQ in a clinical population and this SDQ version's measurement invariance across community and clinical populations, we deem our study to be exploratory because these aspects were not covered by previous studies. Additionally, we do not have expectations of the extent to which our findings will support the sum score method as used in practice to calculate SDQ scale scores.

Method {#section1-1073191118804082}
======

Participants {#section2-1073191118804082}
------------

### Clinical Sample {#section3-1073191118804082}

The clinical sample consists of 12- to 17-year-old adolescents who, between January 1st of 2013 and December 31st 2015, were referred for the first time to one of 29 clinics of an institution for child and adolescent psychiatry in the North of the Netherlands. A total sample of 5,081 adolescents were eligible for this study. During the intake assessment, as part of routine outcome monitoring, data were collected online from these adolescents and their parents. For 4,053 of them, adolescent-reported SDQ data (*n* = 354), parent-reported SDQ data (*n* = 206), or both (*n* = 3,493) were available. Among these adolescents, the mean age was 14.2 years (*SD* = 1.6) among males (46.9%), and 14.6 years (*SD* = 1.5) among females (51.6%). [Table 1](#table1-1073191118804082){ref-type="table"} presents additional demographic and geographic characteristics of the clinical sample.

###### 

Demographic and Geographic Characteristics of the Adolescents in the Clinical and Community Sample.
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  Characteristics                          Clinical, *n* (%)                                                     Community, *n* (%)
  ---------------------------------------- --------------------------------------------------------------------- -------------------------------------------------------------------
  Gender                                                                                                         
   Male                                    1,902 (46.9)^[a](#table-fn1-1073191118804082){ref-type="table-fn"}^   474 (49.3)^[b](#table-fn2-1073191118804082){ref-type="table-fn"}^
   Female                                  2,093 (51.6)                                                          482 (50.1)
  Native country mother                                                                                          
   Netherlands                             ^[c](#table-fn3-1073191118804082){ref-type="table-fn"}^               754 (78.4)^[d](#table-fn4-1073191118804082){ref-type="table-fn"}^
   Other                                   ^[c](#table-fn3-1073191118804082){ref-type="table-fn"}^               149 (15.5)
  Educational level mother                                                                                       
   Low                                     ^[c](#table-fn3-1073191118804082){ref-type="table-fn"}^               187 (19.4)^[e](#table-fn5-1073191118804082){ref-type="table-fn"}^
   Medium                                  ^[c](#table-fn3-1073191118804082){ref-type="table-fn"}^               281 (29.2)
   High                                    ^[c](#table-fn3-1073191118804082){ref-type="table-fn"}^               282 (29.3)
  Geographical region of the Netherlands                                                                         
   North                                   2,563 (63.2)^[f](#table-fn6-1073191118804082){ref-type="table-fn"}^   51 (5.3)^[g](#table-fn7-1073191118804082){ref-type="table-fn"}^
   East                                    1,452 (35.8)                                                          164 (17.0)
   South                                   4 (0.1)                                                               155 (16.1)
   West                                    24 (0.6)                                                              367 (38.1)
  Age, years                                                                                                     
   12                                      581 (14.3)^[h](#table-fn8-1073191118804082){ref-type="table-fn"}^     56 (5.8)
   13                                      741 (18.3)                                                            315 (32.7)
   14                                      767 (18.9)                                                            281 (29.2)
   15                                      799 (19.7)                                                            117 (12.2)
   16                                      678 (16.7)                                                            107 (11.1)
   17                                      487 (12.0)                                                            77 (8.0)

Missing: *n* = 58 (1.4%).

Missing: *n =* 6 (0.6%).

Information not available.

Missing: *n* = 100 (10.5%).

Missing: *n* = 212 (22.0%).

Missing: *n =* 10 (0.3%).

Missing: *n* = 225 (23.4%).

Missing: *n* = 9 (0.9%).

[Table 2](#table2-1073191118804082){ref-type="table"} provides an overview of the *Diagnostic and Statistical Manual of Mental Disorders--Fourth edition* (*DSM-IV*) diagnoses, as established by trained professionals in a multidisciplinary team, generally consisting of at least a child and adolescent psychiatrist and a child psychologist, supplemented with additional professionals such as a specialized nurse. Of the 4,053 adolescents in the sample, 2,812 had received a diagnosis in any of the four categories that contentwise respond to the SDQ scales. The remaining adolescents were not diagnosed with a *DSM-IV* disorder or their diagnosis was unknown (*n* = 628, 15.5%) or had received other *DSM* diagnoses (*n* = 609, 15.1%). The second column of the table shows that anxiety/mood disorders were most prevalent, and conduct/oppositional defiant disorder least. Per *DSM-IV* disorder (row), columns three through six provide information about the comorbidity of disorders. Most prevalent is attention-deficit/hyperactivity disorder within the group with conduct/oppositional defiant disorder.

###### 

Prevalence of *DSM-IV* Diagnoses and Comorbidity Between *DSM-IV* Diagnoses.
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  *DSM* category          *N* ^[a](#table-fn10-1073191118804082){ref-type="table-fn"}^   Comorbid with . . .               
  ----------------------- -------------------------------------------------------------- --------------------- ----- ----- -----
  ADHD                    913                                                            ---                   .18   .14   .16
  Anxiety/mood disorder   1,372                                                          .09                   .03   ---   .09
  ASD                     719                                                            .20                   .04   .18   ---
  CD/ODD                  391                                                            .42                   ---   .09   .08

*Note. DSM-IV* = *Diagnostic and Statistical Manual of Mental Disorders--Fourth edition*; ADHD = attention-deficit/hyperactivity disorder; CD/ODD = conduct/oppositional defiant disorder; ASD = autism spectrum disorder.

The numbers in this column add up to more than 2,412 (number of adolescent in the sample with a diagnosis in any of the four categories) due to comorbidity.

The proportion of adolescents within each *DSM* category (row), also diagnosed with any of the other disorders.

### Community Sample {#section4-1073191118804082}

Within the community sample of 12- to 17-year-old adolescents, data were collected in three waves. The first wave of adolescent- and parent-reported SDQ data were collected in 2009 and 2010, in the East, South, and West of the Netherlands. The data were collected as part of a routine well-child care check provided regularly to all Dutch adolescents during their second year in secondary education (13- or 14-year-olds). The second wave of data, also collected among 13- or 14-year-old adolescents, consisted only of adolescent-reported SDQ data and was collected in 2010 at six secondary schools in the West of the Netherlands. The sample resulting from these two waves consists of 519 adolescents for whom adolescent-reported SDQ data (*n* = 217), parent-reported SDQ data (*n* = 28), or both (*n* = 274) were available. The third wave of data consisted of adolescent- and parent-reported data and was gathered in 2016 and 2017 via schools throughout the Netherlands as part of a norming study of an intelligence test. The resulting sample consists of 443 adolescents for whom adolescent-reported SDQ data (*n* = 220), parent-reported SDQ data (*n* = 17), or both (*n* = 206) were available.

In total, the community sample consisted of 962 adolescents, for whom adolescent-reported SDQ data (*n* = 437), parent-reported SDQ data (*n* = 45), or both (*n* = 480) were available. Within this group, the mean age was 14.1 years (*SD* = 1.4) among males (49.3%) and 14.2 years (*SD* = 1.4) among females (50.1%). Other demographic and geographic characteristics of the community sample are presented in [Table 1](#table1-1073191118804082){ref-type="table"}. When compared with summary statistics published by [@bibr28-1073191118804082], the community sample appears to be representative of the Dutch adolescent population regarding gender, ethnicity, and mothers' educational level.

[Table 1](#table1-1073191118804082){ref-type="table"} presents information about the age distribution within the clinical and community samples. This information shows that 13- and 14-year-old adolescents are more heavily represented in the community sample (62.6%) than in the clinical sample (37.2%). This overrepresentation results from the initial data gathering as part of the well-child care check, which is provided to adolescents at approximately the age of 13 or 14 years.

Strengths and Difficulties Questionnaire {#section5-1073191118804082}
----------------------------------------

Adolescents and their parents completed the Dutch version of the SDQ adolescent and parent versions, respectively ([@bibr32-1073191118804082]). The 25-item questionnaires both consist of four subscales of five items focusing on difficulties relating to behavior, emotional functioning, hyperactivity and interaction with peers, and one subscale of five items focusing on prosocial behavior, which is considered a strength ([@bibr9-1073191118804082]). For each item, a 3-point rating scale (0 = *not true*, 1 = *somewhat true*, and 2 = *certainly true*) rates the degree to which either the adolescent considers the attribute applicable to oneself, or the parent considers it applicable to the adolescent. Five positively worded items belonging to different SDQ scales are reverse-coded. High scores on the four difficulties scales, represent a high degree of difficulties; a high score on the prosocial scale represents a high degree of prosocial behavior. As is recommended in the SDQ's scoring manual, SDQ scale scores were calculated by summing the item scores per scale while accounting for missing values as long as no more than two item scores per scale are missing. This method is called the sum score method in this article.

Statistical Analysis {#section6-1073191118804082}
--------------------

### Missing Data {#section7-1073191118804082}

The clinical sample contained no missing data; the community sample data set contained some missing data for the SDQ adolescent version (*M* = 0.33%, *SD* = 0.32, minimum = 0%, maximum = 1.2%) and the SDQ parent version (*M* = 0.38%, *SD* = 0.28, minimum = 0%, maximum = 0.8%). Considering the small number of missing data, we opted for two-way imputation with normally distributed errors to impute these data (e.g., [@bibr8-1073191118804082]).

### Measurement Invariance {#section8-1073191118804082}

First, the presumed five-factor structure, or in case the presumed five-factor does not fit adequately the six-factor structure, was modelled using single group (i.e., setting) confirmatory factor analysis (CFA) for ordinal data ([@bibr18-1073191118804082]).

This resulted in four single group CFA's, one for each setting (2: clinical, community) per SDQ version (2: adolescent, parent). Second, measurement invariance of the SDQ versions across settings was evaluated using multiple-group CFA models for ordinal data (see, e.g., [@bibr17-1073191118804082]). Per SDQ version a set of four successive multiple-group CFA models (described below) was estimated. Each model within a set imposed additional constraints on the preceding model to examine whether the parameters of the models were equal across clinical and community settings, and thus whether measurement invariance would apply.

The first in each set of measurement invariance models was used to test configural invariance across settings. Configural invariance implies that the hypothesized factor structure (i.e., the position of the nonzero loadings) holds across both the clinical and community settings. For identification of the model, the following constraints were applied (following [@bibr17-1073191118804082]): In both settings, item intercepts were fixed to zero and the variances of the common factors to one; in the reference setting (i.e., the clinical setting), the residual variance of each continuous latent response variable was fixed to one and the mean of each common factor to zero; one threshold per variable and one additional threshold for the first item loading on each factor were constrained to be equal across settings.

If the configural invariance model fitted insufficiently, covariances between pairs of item residuals were allowed. To determine which covariance(s) to allow, we selected one residual covariance to free in the model using the modification indices of item pairs that belonged to the same factor, thereby selecting the one with the largest modification index of those indices with a value larger than 10, and the model was rerun. We repeated this process until the model fitted sufficiently or the model was rerun 10 times. We chose 10 residual covariances as the limit, because we considered allowing that many covariances or more to be an indication of factors beyond the factors tested. If that model would not fit adequately, we fitted the six-factor model using the same procedure.

Next, measurement invariance models were estimated to test metric, strong, and strict invariance, respectively. Metric invariance implies the equivalence of the factor loadings across settings. Strong invariance implies that SDQ factors and their underlying items are of equal meaning in both settings. Strict invariance implies that the latent trait was measured identically in both settings. Each consecutive model imposed additional constraints to its preceding model: equal factor loadings across settings (metric), equal thresholds across settings (strong), and equal residual variances across settings (strict).

All CFA models were estimated using M*plus* version 8 ([@bibr19-1073191118804082]), using weighted least squares mean and variance adjusted estimation. The goodness-of-fit of the models was assessed by considering the root mean square error of approximation (RMSEA) value ([@bibr29-1073191118804082]) and the comparative fit index (CFI;: [@bibr2-1073191118804082]). We consider RMSEA values ⩽.08 combined with CFI values ⩾.90 to be acceptable, while we prefer RMSEA values ⩽.06 together with CFI values ⩾.95 are preferred, as is recommended by [@bibr12-1073191118804082]. The goodness-of-fit of the measurement invariance models was additionally assessed by considering the change in CFI (ΔCFI), which represents the change in CFI value between pairs of successive models. Ideally, model fit does not decrease from one model to the next. In other words, the CFI values should stay more or less the same, considering a decrease of .01 or less as acceptable (ΔCFI ⩽ .01, [@bibr4-1073191118804082]). The fit measures mentioned take the number of model parameters into account. Consequently, fit statistics may indicate a more constrained model to fit slightly better than its preceding less constrained model purely as a result of the decreased number of parameters. For the sake of completeness and comparability with similar studies, Tucker--Lewis index (TLI) values, chi-square values, their corresponding degrees of freedom, and the chi-square Difftest outcomes are also presented. The TLI values were not interpreted, because they are highly correlated with the aforementioned CFI values and do not provide much additional information. Besides, the CFI is a more commonly used fit measure than the TLI. The chi-square information was not interpreted, because the accuracy of chi-square tests relies heavily on the assumption that scores are normally distributed ([@bibr25-1073191118804082]) and thus are often misrepresenting the data.

### Selecting a Model Per SDQ Version {#section9-1073191118804082}

Per SDQ version, the presumed five-factor structure was evaluated first, because it most closely resembles how the SDQ is used in practice. The five-factor solution was selected for further examination if the RMSEA and CFI values showed sufficient fit. In case they did not, the fit of the six-factor alternative was evaluated with the same sequence of single group and multiple-group CFA's as described above.

For the selected model per SDQ version, effect size $\hat{d}$, indicating the number of standard deviations that the means of the clinical and community sample differ from each other, was used to interpret differences in factor means between the two settings ([@bibr5-1073191118804082]). We considered effect sizes ⩾.50 as medium, and ⩾.80 as large.

The reliability per SDQ scale was estimated through the Omega coefficient ([@bibr16-1073191118804082]), which is a suitable measure as it allows unequal item loadings per factor (nontau-equivalence) and allows residual item variances to be uncorrelated. SDQ scales are considered sufficiently reliable when ω ⩾ .70, while ⩾.80 is preferred ([@bibr6-1073191118804082]). Cronbach's alpha is reported for the sake of comparability to other studies.

### Evaluating the Sum Score Method as Used in Practice {#section10-1073191118804082}

In practice, each SDQ scale score is calculated by summing the item scores of the items pertaining to that particular scale while accounting for missing values as long as no more than two item scores per scale are missing. The five-factor structure evaluated in this study resembles that method in the sense that it assumes the same division of items over factors. Unlike the sum score method, the five-factor structure does not assume equal weighting across items per factor, and takes dependency between factors into account. As a result, the factor scores associated with the five-factor CFA solution are not necessarily equal to the sum scores. Per SDQ version and SDQ scale, the use of the sum score method was evaluated by examining the association, expressed as Spearman rank correlation coefficients (rho), between the sum scores and the factor scores of the factor in the CFA associated with that SDQ scale. Note that the positive construal method factor from the six-factor model was not taken into account as no corresponding SDQ scale exists. We consider Spearman ρ's \> .85 to be supportive of the continued use of sum scores in practice.

Results {#section11-1073191118804082}
=======

The SDQ Adolescent Version {#section12-1073191118804082}
--------------------------

[Table 3](#table3-1073191118804082){ref-type="table"} presents the goodness-of-fit statistics of the single group CFA's in the clinical and community settings, and the table presents the goodness-of-fit statistics for the successive multiple-group CFA models used to test measurement invariance across these settings.

###### 

Goodness-of-Fit Statistics of the Presumed Five-Factor Structure and the Six-Factor Structure for the SDQ Adolescent Version.

![](10.1177_1073191118804082-table3)

  Model                                                                         χ^2^       *df*   *p*      χ^2^ Difftest   *df* Difftest   *p*      RMSEA   RMSEA 90% \[CI\]   CFI    ΔCFI   TLI
  ----------------------------------------------------------------------------- ---------- ------ -------- --------------- --------------- -------- ------- ------------------ ------ ------ ------
  *Five-factor model as hypothesized by Goodman*                                                                                                                                             
  Single group                                                                                                                                                                               
   Clinical                                                                     4885.508   265    \<.001                                            .067    \[.066, .069\]     .850          .831
   Community                                                                    772.988    265    \<.001                                            .046    \[.042, 049\]      .896          .883
  Multiple group                                                                                                                                                                             
   Configural inv. I                                                            5451.699   530    \<.001                                            .062    \[.061, .064\]     .859          .840
   Configural inv. II^[a](#table-fn13-1073191118804082){ref-type="table-fn"}^   4271.369   510    \<.001                                            .056    \[.054, .057\]     .892          .873
  *Six-factor model (including the positive construal method factor)*                                                                                                                        
  Single group                                                                                                                                                                               
   Clinical                                                                     3862.007   255    \<.001                                            .061    \[.059, .062\]     .883          .863
   Community                                                                    525.249    255    \<.001                                            .034    \[.030, .038)      .945          .935
  Multiple group                                                                                                                                                                             
   Configural inv. I                                                            4210.048   510    \<.001                                            .055    \[.054, .057\]     .894          .875
   Configural inv. II^[b](#table-fn14-1073191118804082){ref-type="table-fn"}^   4593.298   518    \<.001                                            .053    \[.052, .055\]     .902          .884
   Metric fact. inv.                                                            3879.459   532    \<.001   119.060         24              \<.001   .051    \[.050, .053\]     .904   .002   .892
   Strong fact. inv.                                                            3852.673   551    \<.001   53.286          19              \<.001   .050    \[.049, .052\]     .905   .001   .897
   Strict fact. inv.                                                            3901.390   577    \<.001   128.589         26              \<.001   .049    \[.048, .051\]     .904   .001   .901

*Note*. SDQ = Strengths and Difficulties Questionnaire; *df* = degrees of freedom; CI = confidence interval; RMSEA = root mean square error of approximation; CFI = comparative fit index; TLI = Tucker--Lewis index; Configural inv. I = configural invariance model with no freed item residual covariances; Configural inv. II = configural invariance model with freed item residual covariances; Metric fact. inv. = metric factorial invariance model; Strong fact. inv. = strong factorial invariance model; Strict fact. inv. = strict factorial invariance model. Clinical group: *n* = 3,847; Community group: *n* = 917.

Item residuals of 10 item pairs (Q1 and Q4, Q1 and Q17, Q2 and Q10, Q2 and Q15, Q4 and Q17, Q9 and Q20, Q10 and Q15, Q15 and Q25, Q16 and Q24, Q18 and Q22) freed.

Item residuals of one item pair (Q2 and Q10) freed.

Presumed Five-Factor Model {#section13-1073191118804082}
--------------------------

The single group CFA's for the SDQ adolescent version yielded acceptable RMSEA values and insufficient CFI values for both settings (clinical: RMSEA = .067, CFI = .850; community: RMSEA = .046; CFI = .896).

The configural invariance model, the first in the set of successive models to test measurement invariance, yielded acceptable RMSEA, and insufficient CFI values (RMSEA = .062, CFI = .859, see configural invariance model I). Modification indices showed interpretable item residual covariances between multiple item pairs. Each item pair consisted of items belonged to the same factor. With ten of these residual item covariances allowed, model fit was still insufficient, with the RMSEA value being acceptable and the CFI value insufficient (RMSEA = .056, CFI = .892, see configural invariance model II). Consequently, the metric, strong, and strict invariance models were not estimated.

Six-Factor Model {#section14-1073191118804082}
----------------

The single group models showed acceptable RMSEA and CFI values for the community setting, and acceptable RMSEA value but insufficient CFI value for the clinical setting (clinical: RMSEA = .061, CFI = .883; community: RMSEA = .034; CFI = .945).

The configural invariance model yielded an acceptable RMSEA value and an insufficient CFI value (RMSEA = .055, CFI = .894; see configural invariance model I). Allowing item residual covariances between one item pair resulted in acceptable model fit (RMSEA = .053, CFI = .902, see configural invariance model II). Acceptable fit was also found for the models measuring metric, strong and strict invariance (metric: RMSEA = .051, CFI = .904; strong: RMSEA = .050, CFI = .905; strict: RMSEA = .049, CFI = .904), indicating measurement invariance across settings. [Figure S1](http://journals.sagepub.com/doi/suppl/10.1177/1073191118804082) ([Supplementary Material 1](http://journals.sagepub.com/doi/suppl/10.1177/1073191118804082); all supplementary materials are available in the online version of the article) shows a representation of this model. The factor loadings, residual covariances, factor means, and factor (co)variances of the strict invariance model are presented in [Table 4](#table4-1073191118804082){ref-type="table"}.

###### 

Unstandardized Parameter Estimates and Standard Errors of the Six-Factor Strict Invariance Model for the SDQ Adolescent Version.

![](10.1177_1073191118804082-table4)

  Factor loadings                                                                                                                                                                                                                                                                                                                                                                                                                            
  ---------------------- ------------------------------------------------------------- -------------------------- ------------- ------------------------------------------------------------------- -------------------------------------------------------------------- ------------- -------------------------------------------------------------- ------- ------- -------------------------------------------------------------- ------- ------
  ES                     Q3                                                            0.63 (.02)                                                                                                   −0.26 (.02)                                                          0.86 (.03)                                                                                                                                                          
  Q8                     1.18 (.04)                                                                                             −0.98 (.04)                                                         0.52 (.03)                                                                                                                                                                                                                               
  Q13                    1.59 (.06)                                                                                             −0.29 (.04)                                                         1.49 (.05)                                                                                                                                                                                                                               
  Q16                    1.03 (.03)                                                                                             −0.95 (.03)                                                         0.46 (.03)                                                                                                                                                                                                                               
  Q24                    1.20 (.04)                                                                                             0.29 (.03)                                                          1.72 (.04)                                                                                                                                                                                                                               
  CP                     Q5                                                            1.02 (.05)                                                                                                   −0.26 (.03)                                                          1.50 (.05)                                                                                                                                                          
  Q7                     0.16 (.05)                                                    0.81 (.06)                 −0.77 (.03)   1.74 (.05)                                                                                                                                                                                                                                                                                                   
  Q12                    0.69 (.04)                                                                                             0.94 (.03)                                                          2.33 (.06)                                                                                                                                                                                                                               
  Q18                    0.69 (.03)                                                                                             0.19 (.02)                                                          1.26 (.03)                                                                                                                                                                                                                               
  Q22                    0.51 (.03)                                                                                             1.15 (.03)                                                          2.18 (.05)                                                                                                                                                                                                                               
  HP                     Q2                                                            0.77 (.03)                                                                                                   −0.71 (.03)                                                          0.77 (.03)                                                                                                                                                          
  Q10                    0.84 (.04)                                                                                             −0.59 (.03)                                                         0.68 (.03)                                                                                                                                                                                                                               
  Q15                    1.68 (.08)                                                                                             −2.02 (.08)                                                         0.15 (.04)                                                                                                                                                                                                                               
  Q21                    0.46 (.04)                                                    0.66 (.04)                 −0.79 (.03)   1.41 (.04)                                                                                                                                                                                                                                                                                                   
  Q25                    1.07 (.04)                                                    0.13 (.03)                 −1.42 (.04)   0.88 (.03)                                                                                                                                                                                                                                                                                                   
  SP                     Q6                                                            0.79 (.04)                                                                                                   −0.24 (.03)                                                          1.22 (.03)                                                                                                                                                          
  Q11                    0.42 (.03)                                                    0.12 (.03)                 1.06 (.03)    1.65 (.03)                                                                                                                                                                                                                                                                                                   
  Q14                    0.84 (.04)                                                    0.38 (.03)                 0.48 (.03)    2.60 (.07)                                                                                                                                                                                                                                                                                                   
  Q19                    0.81 (.04)                                                                                             0.81 (.03)                                                          1.96 (.05)                                                                                                                                                                                                                               
  Q23                    0.54 (.03)                                                                                             0.05[\*](#table-fn16-1073191118804082){ref-type="table-fn"} (.02)   1.23 (.03)                                                                                                                                                                                                                               
  PB                     Q1                                                            1.37 (.08)                                                                                                   −3.80 (0.15)                                                         −0.77 (.04)                                                                                                                                                         
  Q4                     0.63 (.03)                                                                                             −1.85 (.04)                                                         −0.41 (.02)                                                                                                                                                                                                                              
  Q9                     0.82 (.04)                                                                                             −2.23 (.05)                                                         −0.51 (.02)                                                                                                                                                                                                                              
  Q17                    0.81 (.04)                                                                                             −2.79 (.08)                                                         −1.11 (.04)                                                                                                                                                                                                                              
  Q20                    0.69 (.03)                                                                                             −1.41 (.03)                                                         0.41 (.02)                                                                                                                                                                                                                               
  Residual covariances                                                                                                                                                                                                                                                                                                                                                                                                                       
                         Item                                                          SDQ scale factor loading                                                                                                                                                                                                                                                                                                                              
                         Q2-Q10                                                        0.42 (.02)                                                                                                                                                                                                                                                                                                                                            
  Factor means                                                                                                                                                                                                                                                                                                                                                                                                                               
                         Clinical Setting                                                                                                                                                           Community Setting                                                    $\hat{d}$                                                                                                                                                           
  ES                     0                                                                                                                                                                          −0.97 (.05)                                                          −1.63                                                                                                                                                               
  CP                     0                                                                                                                                                                          −1.50 (.10)                                                          −1.08                                                                                                                                                               
  HP                     0                                                                                                                                                                          −0.91 (.05)                                                          −1.49                                                                                                                                                               
  SP                     0                                                                                                                                                                          −0.85 (.07)                                                          −0.97                                                                                                                                                               
  PB                     0                                                                                                                                                                          0.04[\*](#table-fn16-1073191118804082){ref-type="table-fn"} (.05)    0.06                                                                                                                                                                
  PCM                    0                                                                                                                                                                          −0.08[\*](#table-fn16-1073191118804082){ref-type="table-fn"} (.09)   −0.07                                                                                                                                                               
  Factor (co)variances                                                                                                                                                                                                                                                                                                                                                                                                                       
                         Clinical setting                                              Community setting                                                                                                                                                                                                                                                                                                                                     
                         ES                                                            CP                         HP            SP                                                                  PB                                                                   PCM           ES                                                             CP      HP      SP                                                             PB      PCM
  ES                     1                                                                                                                                                                                                                                                             0.75                                                                                                                                                  
  CP                     0.21                                                          1                                                                                                                                                                                               0.37                                                           1.80                                                                                   
  HP                     0.31                                                          0.56                       1                                                                                                                                                                    0.31                                                           0.68    0.89                                                                           
  SP                     0.62                                                          0.26                       0.13          1                                                                                                                                                      0.57                                                           0.75    0.20    1.23                                                                   
  PB                     0.03[\*](#table-fn16-1073191118804082){ref-type="table-fn"}   −0.54                      −0.25         −0.22                                                               1                                                                                  −0.01[\*](#table-fn16-1073191118804082){ref-type="table-fn"}   −0.63   −0.22   −0.35                                                          0.84    
  PCM                    −0.18                                                         0.68                       0.45          −0.14                                                               −0.64                                                                1             −0.09                                                          0.43    0.32    −0.07[\*](#table-fn16-1073191118804082){ref-type="table-fn"}   −0.55   0.91

*Note.* SDQ = Strengths and Difficulties Questionnaire; ES = emotional symptoms; CP = conduct problems; HP = hyperactivity/attention problems; SP = social problems; PB = prosocial behavior; PCM = positive construal method.

*p* \> .01 (for all other values *p* \< .01).

Adolescents in the community and clinical settings differed from each other regarding their mean psychosocial strengths and difficulties scores: compared with the community setting, lower factor means were found in the clinical setting for the factors concerning difficulties (emotional difficulties: $\hat{d}$ = −1.63; conduct problems: $\hat{d}$ = −1.08; hyperactivity/attention problems: $\hat{d}$ = −1.49; social problems: $\hat{d}$ = −0.97), with the effect sizes being large. The settings did not significantly differ from each other with regard to the factor means for the strengths factor and the positive construal methods factor (prosocial behavior: $\hat{d}$ = 0.06, positive construal methods: $\hat{d}$ = −0.07).

Adequate reliability was found for the SDQ emotional difficulties, hyperactivity/inattention, and prosocial behavior scales in the clinical and community setting, respectively (emotional difficulties: ω = .85, ω = .81; hyperactivity: ω = .80, ω = .79; prosocial behavior: ω = .77, ω = .74). The conduct problems scale and the social problems scale showed to be insufficiently reliable in the clinical setting (conduct problems: ω = .65; social problems: ω = .69), and adequately reliable in the in the community setting (conduct problems: ω = .76, social problems: ω = .73).

The SDQ Parent Version {#section15-1073191118804082}
----------------------

[Table 5](#table5-1073191118804082){ref-type="table"} presents the goodness-of-fit statistics of the single group CFA's in the clinical and community settings, and for the successive multiple-group CFA models used to test measurement invariance across these settings.

###### 

Goodness-of-Fit Statistics of the Presumed Five-Factor Structure for the SDQ Parent Version.

![](10.1177_1073191118804082-table5)

  Five-factor model as hypothesized by Goodman                                                                                                                          
  ----------------------------------------------------------------------------- ---------- ----- -------- --------- ---- -------- ------ ---------------- ------ ------ ------
  Single group                                                                                                                                                          
   Clinical                                                                     6843.082   265   \<.001                           .082   \[.080, .084\]   .848          .828
   Community                                                                    580.887    265   \<.001                           .048   \[.042, .053\]   .926          .916
  Multiple group                                                                                                                                                        
   Configural inv. I                                                            6785.219   530   \<.001                           .075   \[.073, .076\]   .862          .844
   Configural inv. II^[a](#table-fn18-1073191118804082){ref-type="table-fn"}^   4972.085   518   \<.001                           .064   \[.062, .065\]   .902          .887
   Metric fact. inv.                                                            4759.011   538   \<.001   62.924    20   \<.001   .061   \[.059, .063\]   .907   .005   .896
   Strong fact. inv.                                                            4660.638   558   \<.001   74.201    20   \<.001   .059   \[.057, .061\]   .909   .002   .903
   Strict fact. inv.                                                            4661.278   589   \<.001   199.904   31   \<.001   .058   \[.056, .059\]   .910   .001   .907

*Note.* SDQ = Strengths and Difficulties Questionnaire; *df =* degrees of freedom; RMSEA = root mean square error of approximation; CI = confidence interval; CFI = comparative fit index; TLI = Tucker--Lewis index; Configural inv. I = configural invariance model with no freed item residual covariances; Configural inv. II = configural invariance model with freed item residual covariances; Metric fact. Inv. = metric factorial invariance model; Strong fact. Inv. = strong factorial invariance model; Strict fact. Inv. = strict factorial invariance model. Clinical group: *n* = 3,699; Community group: *n* = 525.

Item residuals of five-item pairs (Q2 and Q10, Q8 and Q13, Q9 and Q20, Q15 and Q25, Q18 and Q22) freed.

Presumed Five-Factor Model {#section16-1073191118804082}
--------------------------

The single group models show insufficient RMSEA and CFI values for the clinical setting (RMSEA = .082, CFI = .848) and acceptable RMSEA and CFI values for the community setting (RSMEA = .048; CFI = .926).

The configural invariance model, yielded an acceptable RMSEA value and an insufficient CFI value (RMSEA = .075, CFI = .862, see configural invariance model I). The second configural invariance model, allowing item residual covariances for five item pairs, yielded acceptable RMSEA and CFI values (RMSEA: .064, CFI: .902, configural invariance model II). The metric invariance model yielded acceptable RMSEA and CFI values (RMSEA = .061, CFI = .907), as did the strong invariance model (RMSEA = .059, CFI = .909) and the strict invariance model (RMSEA: .058, CFI = .910). These results indicate measurement invariance across settings. [Figure S2](http://journals.sagepub.com/doi/suppl/10.1177/1073191118804082) ([Supplementary Material 2](http://journals.sagepub.com/doi/suppl/10.1177/1073191118804082)) shows a representation of the strict invariance model; the factor loadings, residual covariances, factor means, and factor (co)variances are presented in [Table 6](#table6-1073191118804082){ref-type="table"}.

###### 

Unstandardized parameter estimates and standard errors of the five-factor strict invariance model for the SDQ parent version.

![](10.1177_1073191118804082-table6)

  Factor loadings                                                                                                                                                                                   
  ---------------------- ------------------ ------------------- ------------------------------------------------------------------- ------------------- ----------- ------- ------- ------- ------- ------
  ES                     Q3                 0.49 (.02)          −0.34 (.02)                                                         0.54 (.02)                                                      
                         Q8                 0.93 (.04)          −1.17 (.04)                                                         0.10 (.03)                                                      
                         Q13                1.02 (.04)          −0.62 (.03)                                                         0.90 (.03)                                                      
                         Q16                1.22 (.05)          −1.25 (.04)                                                         0.29 (.03)                                                      
                         Q24                1.19 (.05)          0.07[\*](#table-fn19-1073191118804082){ref-type="table-fn"} (.03)   1.47 (.05)                                                      
  CP                     Q5                 0.85 (.03)          −0.21 (.03)                                                         1.04 (.03)                                                      
                         Q7                 1.23 (.05)          −0.50 (.03)                                                         1.47 (.05)                                                      
                         Q12                1.01 (.04)          1.12 (.04)                                                          2.51 (.07)                                                      
                         Q18                0.99 (.04)          0.09 (.03)                                                          1.39 (.04)                                                      
                         Q22                0.66 (.03)          0.92 (.03)                                                          1.66 (.04)                                                      
  HP                     Q2                 0.69 (.03)          −0.16 (.02)                                                         0.97 (.03)                                                      
                         Q10                0.61 (.03)          −0.08 (.02)                                                         0.80 (.03)                                                      
                         Q15                1.12 (.05)          −1.50 (.05)                                                         −0.21 (.03)                                                     
                         Q21                1.21 (.05)          −0.98 (.04)                                                         0.80 (.04)                                                      
                         Q25                0.98 (.04)          −1.17 (.04)                                                         0.27 (.03)                                                      
  SP                     Q6                 0.58 (.03)          −0.40 (.02)                                                         0.67 (.03)                                                      
                         Q11                0.82 (.04)          0.37 (.03)                                                          1.40 (.04)                                                      
                         Q14                1.56 (.09)          0.56 (.05)                                                          3.07 (.13)                                                      
                         Q19                0.88 (.04)          0.44 (.03)                                                          1.67 (.04)                                                      
                         Q23                0.55 (.03)          0.23 (.02)                                                          1.26 (.03)                                                      
  PB                     Q1                 2.84 (.33)          −3.91 (.40)                                                         0.44 (.08)                                                      
                         Q4                 1.04 (.04)          −1.96 (.05)                                                         −0.50 (.03)                                                     
                         Q9                 0.83 (.03)          −1.85 (.04)                                                         −0.46 (.03)                                                     
                         Q17                0.79 (.04)          −2.62 (.07)                                                         −1.20 (.04)                                                     
                         Q20                0.61 (.03)          −0.85 (.03)                                                         0.50 (.02)                                                      
  Residual covariances                                                                                                                                                                              
  Q2-Q10                 0.55 (.02)                                                                                                                                                                 
  Q8-Q13                                    0.55 (.02)                                                                                                                                              
  Q9-Q20                                    0.42 (.02)                                                                                                                                              
  Q15-Q25                                   0.51 (.02)                                                                                                                                              
  Q18-Q22                                   0.64 (.02)                                                                                                                                              
  Factor means                                                                                                                                                                                      
                                            Clinical Setting                                                                        Community Setting   $\hat{d}$                                   
  ES                     0                                                                                                          −1.69 (.08)         −1.61                                       
  CP                     0                                                                                                          −1.21 (.08)         −1.19                                       
  HP                     0                                                                                                          −1.33 (.07)         −1.41                                       
  SP                     0                                                                                                          −1.09 (.09)         −0.88                                       
  PB                     0                                                                                                          0.61 (.07)          0.65                                        
  Factor (co)variances                                                                                                                                                                              
                         Clinical setting   Community setting                                                                                                                                       
                         ES                 CP                  HP                                                                  SP                  PB          ES      CP      HP      SP      PB
  ES                     1                                                                                                                                          1.16                            
  CP                     0.13               1                                                                                                                       0.43    0.70                    
  HP                     0.10               0.73                1                                                                                                   0.53    0.63    1.27            
  SP                     0.47               0.41                0.25                                                                1                               0.89    0.43    0.53    1.49    
  PB                     −0.08              −0.71               −0.39                                                               −0.50               1           −0.26   −0.44   −0.40   −0.73   1.04

ES = emotional symptoms, CP = conduct problems, HP = hyperactivity/attention problems, SP = social problems, PB = prosocial behaviour \**p* \> .01.

For all other values p \< .01.

Parental responses in the community and clinical settings differed from each other regarding their mean psychosocial strengths and difficulties scores, as can be seen in [Table 6](#table6-1073191118804082){ref-type="table"}. Compared with the clinical setting, lower factor means for the factors concerning difficulties and a higher factor mean for the strengths factor were found in the community setting (emotional difficulties: $\hat{d}$ = −1.62; conduct problems: $\hat{d}$ = −1.20; hyperactivity/attention problems: $\hat{d}$ = −1.41; social problems: $\hat{d}$ = −0.88, and prosocial behavior: $\hat{d}$ = 0.66), with the effect sizes regarding the difficulties factors being large and the effect size for the strengths factor being medium.

Adequate reliabilities were found for all scales in the clinical and community setting, respectively (emotional difficulties: ω = .81, ω = .83; conduct problems: ω = .81, ω = .76; hyperactivity/inattention problems: ω = .80, ω = .83; social problems: ω = .77, ω = .82; prosocial behavior: ω = .82, ω = .83).

Evaluating the Sum Score Method Used in Practice {#section17-1073191118804082}
------------------------------------------------

[Table 7](#table7-1073191118804082){ref-type="table"} shows Spearman rank correlations between the SDQ scale sum scores, which resemble current practice, and factor scores resulting from the CFA analyses. All correlations provided support for the continued use of sum scores in practice, with correlations for the SDQ adolescent version ranging from .90 for conduct problems scale to .98 for the hyperactivity/attention problems scale, and for SDQ parent version ranging from .92 for the prosocial behavior scale to .97 for the emotional problems scale. For the sake of comparability with other studies, [Table 7](#table7-1073191118804082){ref-type="table"} additionally presents Cronbach's alpha coefficient per SDQ scale.

###### 

Per SDQ Version and Scale, Cronbach's α and Spearman Rank Correlation Coefficients Between SDQ Scale Scores and Factor Scores.^[a](#table-fn22-1073191118804082){ref-type="table-fn"}^

![](10.1177_1073191118804082-table7)

  SDQ scale   SDQ adolescent version   SDQ parent version          
  ----------- ------------------------ -------------------- ------ -----
  ES          .976                     .79                  .973   .78
  CP          .900                     .60                  .933   .74
  HP          .967                     .77                  .959   .78
  SP          .908                     .56                  .925   .68
  PB          .931                     .64                  .916   .75

*Note*. SDQ = Strengths and Difficulties Questionnaire; ES = emotional symptoms; CP = conduct problems; HP = hyperactivity/attention problems; SP = social problems; PB = prosocial behavior.

For all correlation coefficients: *p* \< .01.

Discussion {#section18-1073191118804082}
==========

This study evaluated the presumed five-factor structure and, if necessary, an alternative factor structure of the SDQ adolescent and the parent versions in clinical and community samples of Dutch adolescents aged 12 to 17 years. Next, measurement invariance of these factor structures across clinical and community settings was investigated. Finally, we evaluated the method of calculating SDQ scale scores as used in practice.

SDQ Adolescent Version: Factor Structure and Measurement Invariance {#section19-1073191118804082}
-------------------------------------------------------------------

For the SDQ adolescent version, the presumed five-factor structure was not supported, in both clinical and community settings. Our study was the first to assess the fit of the five-factor structure in a clinical setting, which prevents us from comparing our results with previous findings. With regard to the community setting our findings are in line with some previous studies (e.g., [@bibr14-1073191118804082]; [@bibr30-1073191118804082]), but not others ([@bibr24-1073191118804082]; [@bibr31-1073191118804082]). Neither differences in age range nor cultural background seem to provide an explanation as our observations are in accordance with findings from some previous studies within samples with a similar age range ([@bibr7-1073191118804082]; [@bibr14-1073191118804082]; [@bibr23-1073191118804082]; [@bibr30-1073191118804082]) but not others ([@bibr24-1073191118804082]; [@bibr31-1073191118804082]), and our findings are in line with findings from some studies also performed in Northeastern European adolescent samples ([@bibr14-1073191118804082]; [@bibr23-1073191118804082]; [@bibr30-1073191118804082]) but not all ([@bibr31-1073191118804082]).

For the SDQ adolescent version, the alternative six-factor solution was preferred over the five-factor solution, suggesting that the presence of reverse-worded items in the difficulties scales affects the SDQ's factor structure. The six-factor structure was found to fit the community data acceptably well, as is in line with findings from [@bibr31-1073191118804082]. Regarding the clinical data, this factor structure was not fully confirmed to fit adequately. Model fit for both settings improved to an acceptable level by allowing item residuals of one pair of items to covary. Allowing this covariance accounts for the presence of a minor factor within one of the factors, as will be explained in more detail later. Furthermore, evidence was found for measurement invariance of this six-factor structure across clinical and community settings. This finding suggests that the SDQ adolescent version is useful for screening purposes, as this SDQ version measures adolescents' strengths and difficulties in the same way in clinical (e.g., during intake preceding thorough diagnostic assessment by clinicians) and community settings (e.g., as part of a routine well-child check-up or at school).

SDQ Parent Version: Factor Structure and Measurement Invariance {#section20-1073191118804082}
---------------------------------------------------------------

For the SDQ parent version, the five-factor structure was supported for the community setting, which is in line with previous findings in similar samples ([@bibr11-1073191118804082]; [@bibr31-1073191118804082]). Regarding the clinical data, we could not fully confirm the fit of this factor structure. Allowing some item residuals to covary improved model fit in both settings. Furthermore, evidence was found for measurement invariance of the five-factor structure across clinical and community settings, as was hypothesized. Extending on [@bibr27-1073191118804082] similar observations regarding children, our findings suggest that the SDQ parent version measures adolescents' strengths and difficulties in the same way in clinical and community settings.

Allowing Item Residual Covariances {#section21-1073191118804082}
----------------------------------

From the CFA's, we learned that some item pairs contributed to their factor and additionally had something else in common, which called for allowing the item residuals of these items to covary. One of these item pairs, Items 2 ("restless, overactive") and 10 ("constantly fidgeting or squirming") of the hyperactivity/attention problems factor, was found for both SDQ versions (i.e., the five-factor model for the SDQ adolescent version and the six-factor model for the SDQ parent version). This finding is consistent with findings from several previous studies among adolescents ([@bibr3-1073191118804082]; [@bibr20-1073191118804082]; [@bibr23-1073191118804082]; [@bibr27-1073191118804082]; [@bibr30-1073191118804082]; [@bibr31-1073191118804082]). Within the same factor, Items 15 ("easily distracted, concentration wanders") and 25 ("sees tasks through to the end") seemed to have something other than belonging to the same factor in common for the SDQ parent version. This finding too is in accordance with findings from a number of previous studies ([@bibr3-1073191118804082]; [@bibr20-1073191118804082]; [@bibr27-1073191118804082]). The persistent findings regarding these two item pairs most likely indicate the presence of minor factors hyperactivity and/or attention within the hyperactivity/attention factor ([@bibr3-1073191118804082]; [@bibr30-1073191118804082]), which is not surprising as the hyperactivity/attention factor's name already suggests heterogeneity within the factor. Although the need for allowing some item residuals to covary indicates that the items measuring the two constructs can to some extent be distinguished from each other, the CFA results imply that the items within the hyperactivity/attention factor are strongly associated, and together can be used to sensibly measure hyperactivity/attention.

Scale Reliabilities Per SDQ Version {#section22-1073191118804082}
-----------------------------------

As was described above, both SDQ versions were found to be measurement invariant, and thus can be used to distinguish at risk adolescents from others *across* settings. Additionally, the scales reliabilities can be used to assess how useful the scales of both SDQ versions are for the purpose of differentiating between adolescents *within* each setting. With the exception of the conduct and social problems scales of the SDQ adolescent version in the clinical setting, all SDQ scales of both SDQ versions were found to be sufficiently reliable in both settings. For the conduct and social scales, the clinical setting data show limited variance in scores compared with the community setting data, resulting in lower reliabilities.

Evaluating SDQ Scales as Currently Used in Practice {#section23-1073191118804082}
---------------------------------------------------

Apart from evaluating the factor structure, the aim of our study was to assess the way the SDQ scores are currently calculated in practice: summing item scores per SDQ scale, using equal weighting of items per scale. This summing method was supported for both SDQ versions by the findings of the current study, as SDQ scale sum scores and its associated factor scores were all highly correlated. This indicated that although unequal weighting of items per SDQ scale would be optimal, the currently used equal weighting yields a fairly reasonable approximation. For the SDQ adolescent version, evidence was found for a six-factor structure including a positive construal method factor. Methodologically this factor is interesting, because it indicates an unintended effect of the positive wording of some items measuring difficulties. For practice, this methodological factor is less interesting as it does not contribute to measurement of psychosocial functioning contentwise; no corresponding SDQ scale exists. Therefore, only the five existing scales were evaluated for use in practice.

Strengths and Limitations {#section24-1073191118804082}
-------------------------

This study focused primarily on evaluating the presumed five-factor structure of the SDQ. If needed, an alternative factor structure was evaluated. It cannot be ruled out that a factor structure other than the ones under investigation would yield an even better representation. However, finding the best fitting factor structure was not the purpose of our study, as our aim was to evaluate factor structures that closely resemble how the SDQ is used in daily practice.

Our study is the first to assess measurement invariance of the SDQ adolescent and parent versions across clinical and community settings. Knowledge about potential measurement invariance helps determine whether SDQ scores from clinical and community settings can be interpreted in the same way, and thus can be compared in practice. Comparing scores across these settings is, for instance, important for clinicians as they are often interested in how a referred adolescent's scores compared with adolescents from a nonclinical population.

Furthermore, the current study evaluates the factor structure and measurement invariance of multiple SDQ versions, whereas most studies investigate the psychometric properties of only one informant version. During adolescence, adolescents themselves are increasingly often used as the informant, but self-reports are potentially more prone to social desirability and biased estimation of their own psychosocial functioning than reports from other informants are. Therefore, the parent is also a frequently used informant. From investigating both versions within similar adolescent samples, we, for instance, learned that reverse-worded items affect the factor structure of the SDQ adolescent version. For the parent version, measurement invariance was found without having to take into account the reverse-worded nature of some of the items.

The current study is subject to four potential limitations. First, approximately half of community sample data were collected about 7 years before the rest of the data were collected. By handling these data as if it were one community sample, we assume that adolescents' and parents' interpretation of the items and thus the factor structure of both SDQ versions has not changed over time. We consider this assumption tenable, given the relatively short time span of about 7 years between collecting both parts of the sample. The tenability of this assumption is further supported by the fact that we found measurement invariance across settings.

The second limitation of the current study is that clinical and community samples are not comparable based on geographical origin and age distribution. The adolescents in the community sample mainly reside in the West, South, and East of the Netherlands, while the adolescents in the clinical sample mainly reside in the North and East of the Netherlands. In the worst case scenario, we may have assessed measurement invariance across geographic regions instead of across settings. The Netherlands is a small and relatively densely populated country, which are characteristics that likely reduce the interpretational differences across geographic regions. Therefore, we deem it to be fairly improbable that our findings regarding measurement invariance are biased by these sample differences. With respect to age, the two samples are incomparable as 13- and 14-year-old adolescents are overrepresented in the community sample. As both samples further contain substantial numbers of 12- and 15- to 17-year-olds and the total age range of our sample is relatively small, we have no reason to believe that this sample difference would cause a violation of measurement invariance of either SDQ version under investigation in this study.

Third, we have not been able to compare the clinical and community samples on characteristics as migration background and social economic status as we had no indicators of these characteristics for the adolescents in the clinical sample and indirect indicators of these characteristics for the community sample. These factors may have confounded our findings.

Fourth, if necessary we adapted our models by using modification indices to determine which, if any, residuals variances to allow, as is a commonly used approach in similar studies. This course of action results in models that are to some extent sample dependent, which may have biased our results. Therefore, we hope that others will try to replicate our findings in other but similar samples.

Implications {#section25-1073191118804082}
------------

The SDQ is used in clinical and community settings, albeit for different purposes. In community settings, mainly consisting of adolescents that do not suffer from psychosocial problems, SDQ scores are used to screen for adolescents at risk of developing psychiatric disorders. In clinical settings, mainly consisting of adolescents with psychosocial problems, SDQ scores are often used to provide a preliminary indication of the problems at hand, which is then more thoroughly considered by clinicians. Although the aim of the use of the SDQ differs across settings, our findings indicate measurement invariance across settings, meaning that the SDQ screens for psychosocial problems in the same way in both settings.

In practice, the SDQ is used to assess an adolescent's psychosocial functioning by comparing the adolescent's SDQ scale scores to community-based norm scores. The scale scores are calculated by summing the item scores per scale. This method is insightful and easy to work with, but also quite blunt as it assumes that all items within a scale measure the construct equally well. Per SDQ version and for each of the five SDQ scales, we compared sum scores and factor scores. For both SDQ versions, strong association was found between sum scores and factor scores, which can be regarded as support for the continued use of the sum score method in practice. Note that the positive construal method factor in the six-factor structure for the adolescent version was not evaluated for use in practice, because this is a methodological factor that does not contribute to measurement of psychosocial functioning contentwise. These findings are encouraging for clinical and community practice as they suggest that SDQ scores of adolescents can be interpreted using community-based norm scores, regardless of whether the adolescent has been referred for mental health problems.

Our findings further show the conduct and social scales of the SDQ adolescent version to be insufficiently reliable within the clinical setting. This suggests that these scales are of limited use for the purpose of differentiating between adolescents within a clinical setting.
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